 |
Market Research Report
Asia-Pacific Nerve Repair Biomaterials Market |
||||||
| Published by | Data Bridge Market Research Private Limited | Product code | 570379 | ||||
| Published | Content info | 150 Pages Delivery time: 1-2 business days |
|||||
| Price |
|
||||||
| Asia-Pacific Nerve Repair Biomaterials Market | ||
| Published: October 1, 2017 | Content info: 150 Pages |
|
In this report, Asia-Pacific nerve repair biomaterials market is projected to reach USD 205.98 million by 2024, from USD 67.57 million in 2016 growing at a CAGR of 15.0% in the forecast period 2017 to 2024.
Based on geography, the APAC nerve repair biomaterials market is segmented into 11 geographical regions, such as,
Japan,
China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of APAC.
APAC nerve repair biomaterials market competition by top players including -
Integra Life Sciences is going to dominate the nerve repair biomaterials market followed by Stryker Corporation and Collagen Matrix, Inc. along with others such as
AxoGen, Inc.,
Checkpoint Surgical, Inc.,
Polyganics,
Synovis Micro Companies Alliance, Inc.
Based on product type, the APAC nerve repair biomaterials market is segmented into nerve repair and nerve protection.
The APAC nerve repair biomaterials market is further segmented into nerve conduits and nerve grafts.
Nerve repair graft is further segmented into allograft and acellularized allograft. Nerve protection market is segmented into nerve protector and nerve wrap.
Based on the injury type, the nerve repair biomaterials market is segmented into epineural nerve repair, perineural nerve repair, and group fascicular repair.
On the basis of end user, the APAC nerve repair biomaterials market is categorized into hospitals, clinics, and ambulatory surgical centres.
